Posted in | News | Nanomedicine

Fast Bioluminescence Imaging Technique Keeping an Eye on Cancer Cells

Scientists from A*STAR in Singapore and the USA have developed a fast bioluminescence imaging technique that may greatly assist in the search for drugs that target mobile-or metastatic-cancer cells.

Chemotherapy treatments for this type of cancer using 'anti-migratory' drugs are important because some of the most mobile cells that cause metastasis can resist conventional cancer drugs. This is a problem because patients tend to be at greater risk of developing metastases over the extended survival periods associated with modern cancer therapies. Using zebrafish as a model organism, researchers could spot as few as eight cells undergoing metastasis from glioblastoma multiforme (GBM)-the most common and aggressive type of brain tumor.

The team, including Beng-Ti Ang from A*STAR's Singapore Institute for Clinical Sciences and co-workers at the University of Singapore and the Methodist Hospital, Cornell University, USA, used a method called gene transfection to develop GBM cells that express a gene from fireflies, causing them to emit light in a process known as bioluminescence. They assessed the 'invasiveness' of the cells by measuring how quickly they moved through a three-dimensional matrix, and found that the most invasive cells express a gene that makes them more mobile. The same gene has also been correlated previously with reduced patient survival.

Click here to read the full press release.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.